Quest Diagnostics To Release Fourth Quarter and Full Year 2009 Financial Results
January 08 2010 - 9:27AM
PR Newswire (US)
MADISON, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE:DGX), the world's leading provider of diagnostic
testing, information and services, announced today that it will
report fourth-quarter and full year 2009 results and provide
financial guidance for 2010 on Monday, January 25, before the
market opens. It will hold its quarterly conference call with
investors to discuss the results beginning at 8:30 a.m. ET on that
day. The public may access the conference call through a live audio
webcast available on Quest Diagnostics' Investor Relations internet
site at http://www.questdiagnostics.com/investor. The conference
call can also be accessed in listen-only mode by dialing
415-228-4961, passcode 3214469. The company suggests participants
dial in approximately 10 minutes before the call. A replay of the
call may be accessed online at
http://www.questdiagnostics.com/investor or by phone at
866-428-3803 for domestic callers, or 203-369-0904 for
international callers. No access code will be required. Telephone
replays will be available from 10:30 a.m. Eastern Time on January
25 until midnight Eastern Time on February 22, 2010. Anyone
listening to the Quest Diagnostics call is encouraged to read the
company's periodic reports, on file with the Securities and
Exchange Commission, including the discussion of risk factors and
historical results of operations and financial condition in those
reports. Quest Diagnostics Incorporated (NYSE:DGX) is the world's
leading provider of diagnostic testing, information and services
that patients and doctors need to make better healthcare decisions.
The company offers the broadest access to diagnostic testing
services through its network of laboratories and patient service
centers, and provides interpretive consultation through its
extensive medical and scientific staff. Quest Diagnostics is a
pioneer in developing innovative new diagnostic tests and advanced
healthcare information technology solutions that help improve
patient care. Additional company information is available at:
http://www.questdiagnostics.com/. Contacts: Kathleen Valentine
(Investors): 973-520-2900 Wendy Bost (Media): 973-520-2800
DATASOURCE: Quest Diagnostics Incorporated CONTACT: Kathleen
Valentine (Investors): +1-973-520-2900, or Wendy Bost (Media):
+1-973-520-2800 Web Site: http://www.questdiagnostics.com/
Copyright